Sharp Daily
No Result
View All Result
Friday, August 29, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home Healthcare

Rwanda recalls drug manufactured in Kenya

Brenda Murungi by Brenda Murungi
January 4, 2024
in Healthcare
Reading Time: 2 mins read

The Rwanda Food and Drugs Authority (RFDA) has initiated a voluntary recall of Fluconazole 200mg tablets produced by Universal Corporation (UCL) Ltd. in Kikuyu, Kenya. The recall encompasses all retail and facility levels, and it was officially announced on January 3, following a prior notification letter from the FDA to UCL regarding discoloration issues observed in the Fluconazole 200mg tablets.

RFDA disclosed that four bulk batches of pink Fluconazole 200mg tablets, which were imported into Rwanda, exhibited white discoloration shortly after their manufacture. The tablets, identified by four batch numbers and slated to expire on January 31 and August 31, 2025, were expected to maintain a pink color until the specified timelines but had transitioned to white prematurely.

In response, the RFDA has directed all importers, central medical stores, wholesalers, RMS branches, retailers, and both public and private health facilities to cease the distribution of the affected Fluconazole 200mg tablet batches. The statement issued by the RFDA emphasizes the necessity for these entities to return the recalled batches to their respective suppliers for proper management.

Fluconazole, utilized in the treatment of severe fungal or yeast infections such as vaginal candidiasis, oropharyngeal candidiasis (thrush), esophageal candidiasis, and other candida infections, demonstrated an unexpected discoloration issue in the identified batches. The RFDA, in the course of an investigation into the presence of the drug on the market, determined that the implicated tablet batches had indeed entered the Rwandan market.

RELATEDPOSTS

Rwanda suspends development cooperation with Belgium over political interference

February 19, 2025

Kagame wins re-election with 99.15% of the vote

July 16, 2024

Importers and suppliers of the affected medication are given a 10-day window, from the date of the official announcement, to report the imported quantities, distribution details, returns, and the remaining stock on hand to the RFDA.

While the Kenyan Ministry of Health has not provided information on the recall status of the drug from hospitals and chemists in Kenya, there are no reports of the pink tablets displaying discoloration in the Kenyan market as of now.

Previous Post

Ichung’wah to LSK: Are you saying there are no corrupt judges?

Next Post

James Orengo terms Ruto’s remarks as reckless and dangerous

Brenda Murungi

Brenda Murungi

Related Posts

Analysis

Kenya’s Interest Rate Cut: A Turning Point for Growth

July 31, 2025
Analysis

Kenya’s CIS market: Q1′ 2025 shows a surge, setting the stage for future expansion.

June 26, 2025
Analysis

Your First Investment should be an emergency fund with Cytonn Money Market Fund

June 16, 2025
Analysis

Kisumu airport to become Kenya’s agro-export powerhouse

April 30, 2025
Healthcare

Health CS Duale launches probe into organ transplant practices

April 25, 2025
Healthcare

Former health CAS Dr. Mercy Mwangangi named SHA CEO

April 15, 2025

LATEST STORIES

The Importance of Including Pension Plans in Corporate Benefits Packages

August 29, 2025

The informal labor market and classical unemployment in the Kenyan context

August 28, 2025

Kenya’s Eurobond yields ease after S&P rating upgrade

August 28, 2025

Kenya’s strategic debt pivot: Smoothing, Strengthening, Sustaining

August 27, 2025

Bank on your paycheck: Invest smart with CMMF

August 26, 2025

Finding Balance: My Journey with Internet Self-Care

August 22, 2025

Why Young Kenyans Cannot Afford to Ignore Private Pensions

August 22, 2025

Strategies for Nairobi to emerge as Africa’s financial hub

August 22, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024